No Data
No Data
MIRA Pharmaceuticals' Shares Soar on Ketamine-Analog Drug Study Results
Stocks to Watch: MIRA Pharmaceuticals, Talis Biomedical
Express News | Mira Pharmaceuticals- Achieves 100% Reversal of Neuropathic Pain With Oral Ketamir-2 in Breakthrough Study
Express News | MIRA Pharmaceuticals Achieves 100% Reversal Of Neuropathic Pain With Oral Ketamir-2 In A Rat Study, Outperforming Oral Ketamine And Showcasing Its Potential As A Significant Treatment For Neuropathic Pain, Setting The Stage For Further Clinical Trials
Express News | Mira Pharmaceuticals-Continues to Work With Research Organizations Like Pharmaseed and Biotrial to Further Validate Ketamir-2's Efficacy and Safety
Express News | Mira Pharmaceuticals- Showcases Significant Progress, Announces Final Phase of Regulatory Work as It Prepares for Ind Submission by Year-End
No Data
AddiBee0925 : so basically it will rise pretty well on Monday PM and then nosedive drastically with the execution of said offering. that's what I figuring
Rafey Jan OP : heheh... just putting the message out there, so everyone can make informed decisions about stock
LooseSpeculator : The offering is closed. Check the filing.
Rafey Jan OP : Are you saying they've sold up to 19 mill stock since auguest 13..?
B_jammin : I don't think they have at least not on the date of filing. I will read again but skimming over it appears they will sell from "time to time" within a 12 month period not greater than 1/3 of the public float.